目的: 分析现阶段癌因性疲乏的研究热点和趋势。方法: 检索Web of Science核心合集收录的癌因性疲乏相关文献,运用CiteSpace 5.8.R1软件对作者、参考文献、机构、国家、领域、关键词进行可视化分析。结果: 共纳入1 270篇文献,总体发文量呈上升趋势,美国居世界首位,中国排名第2;其研究机构主要集中在美国的高校和癌症研究中心;研究热点主要集中在癌因性疲乏的机制和危险因素、症状评估与筛查、预防及治疗,研究的对象主要为乳腺癌患者。结论: 目前我国对癌因性疲乏的研究逐渐重视,但其影响力还不足,在未来,就相关领域的研究者、机构及不同学科之间应加强合作。
Objective: To analyze the current research hotspots and trends of cancer-related fatigue(CRF). Methods: Retrieval of related literatures on cancer-related fatigue included in the Web of Science Core Collection was performed, using CiteSpace5.8.R1 to analyze authors, institutions, countries, categories, references, and keywords. Results: A total of 1 270 literatures were included, and the number of publications in terms of CRF is rising. The United States ranks first in the world in total publications of this field, and China ranks second. American universities and cancer research centers are mainly concentrated institutions. The research hotspots mainly focus on the mechanism and risk factors of CRF, symptom assessment, CRF screening, prevention and treatment, and breast cancer patients were mainly studied. Conclusion: At present, our country has gradually paid more attention to the research on CRF, although its influence is not enough. In the future, cooperation among researchers, institutions and medical staff from different disciplines should strengthened.
[1] Ebede CC, Jang Y, Escalante CP. Cancer-related fatigue in cancer survivorship[J]. Med Clin North Am, 2017, 101(6): 1085-1097.
[2] Adam S, van de Poll-Franse LV, Mols F, et al. The association of cancer-related fatigue with all-cause mortality of colorectal and endometrial cancer survivors: results from the population-based PROFILES registry[J]. Cancer Med, 2019, 8(6): 3227-3236.
[3] Jones JM, Olson K, Catton P, et al. Cancer-related fatigue and associated disability in post-treatment cancer survivors[J]. J Cancer Surviv, 2016, 10(1): 51-61.
[4] Chen CM, Hu ZG, Liu SB, et al. Emerging trends in regenerative medicine: a scientometric analysis in CiteSpace[J]. Expert Opin Biol Ther, 2012, 12(5): 593-608.
[5] Ellegaard O, Wallin JA. The bibliometric analysis of scholarly production: how great is the impact [J]. Scientometrics, 2015, 105(3): 1809-1831.
[6] Berger AM, Mooney K, Alvarez-Perez A, et al. Cancer-related fatigue, version 2.2015[J]. J Natl Compr Canc Netw, 2015, 13(8): 1012-1039.
[7] Bower JE. Cancer-related fatigue: mechanisms, risk factors, and treatments[J]. Nat Rev Clin Oncol, 2014, 11(10): 597-609.
[8] Mustian KM, Alfano CM, Heckler C, et al. Comparison of pharmaceutical, psychological, and exercise treatments for cancer-related fatigue: a meta-analysis[J]. JAMA Oncol, 2017, 3(7): 961-968.
[9] Bower JE, Bak K, Berger A, et al. Screening, assessment, and management of fatigue in adult survivors of cancer: an American society of clinical oncology clinical practice guideline adaptation[J]. J Clin Oncol, 2014, 32(17): 1840-1850.
[10] Kangas M, Bovbjerg DH, Montgomery GH. Cancer-related fatigue: a systematic and meta-analytic review of non-pharmacological therapies for cancer patients[J]. Psychol Bull, 2008, 134(5): 700-741.
[11] 陈悦, 陈超美, 刘则渊, 等. CiteSpace知识图谱的方法论功能[J]. 科学学研究, 2015, 33(2): 242-253.
[12] Bower JE, Asher A, Garet D, et al. Testing a biobehavioral model of fatigue before adjuvant therapy in women with breast cancer[J]. Cancer, 2019, 125(4): 633-641.
[13] Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249.
[14] Davis LE, Bubis LD, Mahar AL, et al. Patient-reported symptoms after breast cancer diagnosis and treatment: a retrospective cohort study[J]. Eur J Cancer, 2018, 101: 1-11.
[15] Abrahams HJG, Gielissen MFM, Schmits IC, et al. Risk factors, prevalence, and course of severe fatigue after breast cancer treatment: a meta-analysis involving 12 327 breast cancer survivors[J]. Ann Oncol, 2016, 27(6): 965-974.
[16] Mao HJ, Bao T, Shen XY, et al. Prevalence and risk factors for fatigue among breast cancer survivors on aromatase inhibitors[J]. Eur J Cancer, 2018, 101: 47-54.
[17] Yang SW, Chu SF, Gao Y, et al. A narrative review of cancer-related fatigue (CRF) and its possible pathogenesis[J]. Cells, 2019, 8(7): 738.
[18] Ma YX, He B, Jiang MY, et al. Prevalence and risk factors of cancer-related fatigue: a systematic review and meta-analysis[J]. Int J Nurs Stud, 2020, 111: 103707.
[19] Fabi A, Bhargava R, Fatigoni S, et al. Cancer-related fatigue: ESMO clinical practice guidelines for diagnosis and treatment[J]. Ann Oncol, 2020, 31(6): 713-723.
[20] Amarsheda S, Bhise AR. Systematic review of cancer-related fatigue instruments in breast cancer patients[J]. Palliat Support Care, 2022, 20(1): 122-128.
[21] Cuesta-Vargas AI, Pajares B, Trinidad-Fernandez M, et al. Inertial sensors embedded in smartphones as a tool for fatigue assessment based on acceleration in survivors of breast cancer[J]. Phys Ther, 2020, 100(3): 447-456.
[22] Sada YH, Poursina O, Zhou H, et al. Harnessing digital health to objectively assess cancer-related fatigue: the impact of fatigue on mobility performance[J]. PLoS One, 2021, 16(2): e0246101.
[23] Thong MSY, van Noorden CJF, Steindorf K, et al. Cancer-related fatigue: causes and current treatment options[J]. Curr Treat Options Oncol, 2020, 21(2): 17.
[24] 周帅, 江锦芳, 张玲, 等. 不同运动疗法对癌症患者癌因性疲乏干预效果的网状Meta分析[J]. 解放军护理杂志, 2021, 38(8): 65-68, 88.
